+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Product & Preparations Manufacturing in Europe - Industry Market Research Report

  • PDF Icon

    Report

  • 16 Pages
  • November 2023
  • Region: Europe
  • IBISWorld
  • ID: 5324198

Better pharmaceuticals: Rising healthcare expenditure across most EU countries supports the industry

Industry operators produce basic pharmaceutical products and pharmaceutical preparations, such as vaccines, antibiotics and antisera. Other activities include manufacturing medicinal chemical and botanical products.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Table of Contents

ABOUT THIS INDUSTRY
  • Industry Definition
  • Main Activities
  • Similar Industries
  • Additional Resources
INDUSTRY AT A GLANCE

INDUSTRY PERFORMANCE
  • Executive Summary
  • Key External Drivers
  • Current Performance
  • Industry Outlook
  • Industry Life Cycle
PRODUCTS & MARKETS
  • Supply Chain
  • Products & Services
  • Demand Determinants
  • Major Markets
  • International Trade
  • Business Locations
COMPETITIVE LANDSCAPE
  • Market Share Concentration
  • Key Success Factors
  • Cost Structure Benchmarks
  • Basis of Competition
  • Barriers to Entry
  • Industry Globalization
MAJOR COMPANIES

OPERATING CONDITIONS
  • Capital Intensity
  • Technology & Systems
  • Revenue Volatility
  • Regulation & Policy
  • Industry Assistance
KEY STATISTICS
  • Industry Data
  • Annual Change
  • Key Ratios
JARGON & GLOSSARY

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novartis International AG
  • Novo Nordisk A/S
  • Merck KGaA
  • Sanofi SA
  • Bayer AG
  • Roche Holding AG
  • AstraZeneca plc
  • GSK plc
  • BioNTech SE
  • Genmab AS

Methodology

Loading
LOADING...